EW Healthcare Partners Amends Bioventus Stake Filing
Ticker: BVS · Form: SC 13G/A · Filed: Jan 22, 2024 · CIK: 1665988
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, investor-update
TL;DR
**EW Healthcare Partners still owns Bioventus stock, confirming their continued investment.**
AI Summary
EW Healthcare Partners Acquisition Fund, L.P. filed an amended Schedule 13G/A on January 22, 2024, indicating their ownership of Bioventus Inc. Class A Common Stock as of December 31, 2023. This filing is an amendment, meaning they previously disclosed their stake. While the specific percentage or share count isn't detailed in this excerpt, the filing confirms EW Healthcare Partners remains a significant institutional investor in Bioventus, which matters to shareholders as large institutional holdings can influence stock stability and investor confidence.
Why It Matters
This filing confirms a major institutional investor, EW Healthcare Partners, continues to hold a position in Bioventus, signaling their ongoing interest in the company's performance.
Risk Assessment
Risk Level: low — This is an informational filing confirming an existing institutional stake, not indicating a major change in ownership or company fundamentals.
Analyst Insight
Investors should note that a major institutional holder, EW Healthcare Partners, continues to hold Bioventus stock, which can be a sign of long-term confidence, but this filing alone doesn't provide new information on their current percentage or any recent changes in their position.
Key Numbers
- 0001665988 — Bioventus Inc. CIK (unique identifier for Bioventus Inc. with the SEC)
- 0001837201 — EW Healthcare Partners Acquisition Fund, L.P. CIK (unique identifier for the reporting entity with the SEC)
- 09075A108 — CUSIP Number (identifies Bioventus Inc. Class A Common Stock)
- 20240122 — Filing Date (the date this SC 13G/A amendment was filed)
- 20231231 — Date of Event (the date as of which the ownership information is reported)
Key Players & Entities
- EW Healthcare Partners Acquisition Fund, L.P. (company) — the reporting person and institutional investor
- Bioventus Inc. (company) — the subject company whose stock is being reported
- Martin P. Sutter (person) — authorized to receive notices for EW Healthcare Partners
- EW HEALTHCARE PARTNERS ACQUISITION FUND GP, L.P. (company) — group member
- EW HEALTHCARE PARTNERS ACQUISITION FUND UGP, LLC (company) — group member
- PETRI VAINIO (person) — group member
- R. SCOTT BARRY (person) — group member
- RON EASTMAN (person) — group member
- WHITE PINE MEDICAL LLC (company) — group member
Forward-Looking Statements
- EW Healthcare Partners will maintain a significant stake in Bioventus Inc. throughout 2024. (EW Healthcare Partners Acquisition Fund, L.P.) — medium confidence, target: 2024-12-31
FAQ
What type of stock does EW Healthcare Partners Acquisition Fund, L.P. hold in Bioventus Inc.?
EW Healthcare Partners Acquisition Fund, L.P. holds Class A Common Stock, par value $0.001 per share, of Bioventus Inc., as stated in the 'Title of Class of Securities' section of the filing.
Who is authorized to receive notices and communications for EW Healthcare Partners Acquisition Fund, L.P. regarding this filing?
Martin P. Sutter is authorized to receive notices and communications for EW Healthcare Partners Acquisition Fund, L.P., with the address 21 Waterway Avenue, Suite 225, The Woodlands, Texas 77380, and phone number (281) 364-1555, as specified in the filing.
What is the CUSIP number for Bioventus Inc.'s Class A Common Stock?
The CUSIP number for Bioventus Inc.'s Class A Common Stock is 09075A108, as listed in the filing under 'CUSIP Number'.
When was the event that required the filing of this Schedule 13G/A?
The date of the event which required the filing of this statement was December 31, 2023, as indicated in the 'Date of Event which Requires Filing of this Statement' section.
Which rule under the Securities Exchange Act of 1934 is this Schedule 13G/A filed under?
This Schedule 13G/A is filed under Rule 13d-1(d) of the Securities Exchange Act of 1934, as indicated by the checked box '☒ Rule 13d-1(d)'.
Filing Stats: 2,037 words · 8 min read · ~7 pages · Grade level 8.2 · Accepted 2024-01-22 16:07:56
Key Financial Figures
- $0.001 — suer) Class A Common Stock, par value $0.001 per share (Title of Class of Securiti
Filing Documents
- d676404dsc13ga.htm (SC 13G/A) — 127KB
- d676404dex991.htm (EX-99.1) — 14KB
- 0001193125-24-012156.txt ( ) — 143KB
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of our knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Date: January 22, 2024 EW HEALTHCARE PARTNERS INDIVIDUALS: ACQUISITION FUND, L.P. By: EW Healthcare Partners Acquisition Fund GP, L.P., /s/ Martin P. Sutter Its General Partner Name: Martin P. Sutter By: EW Healthcare Partners Acquisition Fund UGP, LLC, Its General Partner /s/ R. Scott Barry Name: R. Scott Barry By: /s/ Martin P. Sutter Name: Martin P. Sutter Title: Managing Director WHITE PINE MEDICAL LLC /s/ Ronald Eastman Name: Ronald Eastman By: EW Healthcare Partners Acquisition Fund, /s/ Petri Vainio L.P., its Managing Member Name: Petri Vainio By: EW Healthcare Partners Acquisition Fund GP, L.P., Its General Partner By: EW Healthcare Partners Acquisition Fund UGP, LLC, Its General Partner By: /s/ Martin P. Sutter Name: Martin P. Sutter Title: Managing Director EW HEALTHCARE PARTNERS ACQUISITION FUND GP, L.P. By: EW Healthcare Partners Acquisition Fund UGP, LLC, Its General Partner By: /s/ Martin P. Sutter Name: Martin P. Sutter Title: Managing Director EW HEALTHCARE PARTNERS ACQUISITION FUND UGP, LLC By: /s/ Martin P. Sutter Name: Martin P. Sutter Title: Managing Director